Your browser doesn't support javascript.
loading
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category.
Kotrova, Michaela; Fronkova, Eva; Svaton, Michael; Drandi, Daniela; Schön, Felix; Hoogeveen, Patricia; Hancock, Jeremy; Skotnicova, Aneta; Schilhabel, Anke; Eckert, Cornelia; Clappier, Emmanuelle; Cazzaniga, Gianni; Schäfer, Beat W; van Dongen, Jacques J M; Ritgen, Matthias; Pott, Christiane; van der Velden, Vincent H J; Trka, Jan; Brüggemann, Monika.
Afiliação
  • Kotrova M; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Fronkova E; CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Svaton M; CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Drandi D; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
  • Schön F; Austrian Academy of Sciences, CeMM Research Center for Molecular Medicine, Vienna, Austria.
  • Hoogeveen P; Hematology Division, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Hancock J; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Skotnicova A; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Schilhabel A; Bristol Genetics Laboratory, Southmead Hospital, Bristol, UK.
  • Eckert C; CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Clappier E; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Cazzaniga G; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Schäfer BW; German Cancer Consortium (DKTK), and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • van Dongen JJM; Hematology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Ritgen M; Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Pott C; Department of Hematology, University Hospital, Zürich, Switzerland.
  • van der Velden VHJ; Department of Immunology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
  • Trka J; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Brüggemann M; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.
Leukemia ; 38(7): 1617-1620, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38760480
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasia Residual Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasia Residual Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha